The Discounted Cash Flow (DCF) valuation of Metropolis Healthcare Ltd (METROPOLIS.NS) is 483.54 INR. With the latest stock price at 1,885.30 INR, the upside of Metropolis Healthcare Ltd based on DCF is -74.4%.
Based on the latest price of 1,885.30 INR and our DCF valuation, Metropolis Healthcare Ltd (METROPOLIS.NS) is a sell. Selling METROPOLIS.NS stocks now will result in a potential gain of 74.4%.
Range | Selected | |
WACC / Discount Rate | 10.8% - 13.4% | 12.1% |
Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
Fair Price | 382.12 - 665.16 | 483.54 |
Upside | -79.7% - -64.7% | -74.4% |
(INR in millions) | Projections | |||||
03-2025 | 03-2026 | 03-2027 | 03-2028 | 03-2029 | 03-2030 | |
Revenue | 13,312 | 14,029 | 15,570 | 16,824 | 17,710 | 19,173 |
% Growth | 10% | 5% | 11% | 8% | 5% | 8% |
Cost of goods sold | (2,789) | (2,792) | (2,944) | (3,022) | (3,022) | (3,108) |
% of Revenue | 21% | 20% | 19% | 18% | 17% | 16% |
Selling, G&A expenses | (3,137) | (3,307) | (3,670) | (3,965) | (4,174) | (4,519) |
% of Revenue | 24% | 24% | 24% | 24% | 24% | 24% |
Research & Development | 0 | 0 | 0 | 0 | 0 | 0 |
% of Revenue | 0% | 0% | 0% | 0% | 0% | 0% |
Net interest & other expenses | (5,477) | (5,772) | (6,406) | (6,922) | (7,287) | (7,889) |
% of Revenue | 41% | 41% | 41% | 41% | 41% | 41% |
Tax expense | (453) | (539) | (636) | (727) | (805) | (913) |
Tax rate | 24% | 25% | 25% | 25% | 25% | 25% |
Net profit | 1,455 | 1,620 | 1,914 | 2,187 | 2,422 | 2,745 |
% Margin | 11% | 12% | 12% | 13% | 14% | 14% |